TY - JOUR AU - Ungaro, R. AU - Mehandru, S. AU - Colombel, J. F. PY - 2017 DA - 2017// TI - Ulcerative colitis JO - Lancet VL - 29 UR - https://doi.org/10.1016/S0140-6736(16)32126-2 DO - 10.1016/S0140-6736(16)32126-2 ID - Ungaro2017 ER - TY - JOUR AU - Harbord, M. AU - Eliakim, R. AU - Carbonnel, F. PY - 2017 DA - 2017// TI - Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management JO - J Crohn's Colitis VL - 11 UR - https://doi.org/10.1093/ecco-jcc/jjx009 DO - 10.1093/ecco-jcc/jjx009 ID - Harbord2017 ER - TY - JOUR AU - Randall, J. AU - Singh, B. AU - George, B. D. PY - 2010 DA - 2010// TI - Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications JO - Br J Surg VL - 97 UR - https://doi.org/10.1002/bjs.6874 DO - 10.1002/bjs.6874 ID - Randall2010 ER - TY - JOUR AU - Øresland, T. AU - Bemelman, W. A. AU - D'Hoore, A. PY - 2015 DA - 2015// TI - European evidence based consensus on surgery for ulcerative colitis JO - J Crohn's Colitis VL - 9 UR - https://doi.org/10.1016/j.crohns.2014.08.012 DO - 10.1016/j.crohns.2014.08.012 ID - Øresland2015 ER - TY - JOUR AU - Ogata, H. AU - Nakamura, M. AU - Hibi, T. PY - 2006 DA - 2006// TI - A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis JO - Gut. VL - 55 UR - https://doi.org/10.1136/gut.2005.081794 DO - 10.1136/gut.2005.081794 ID - Ogata2006 ER - TY - JOUR AU - Komaki, Y. AU - Komaki, F. AU - Sakuraba, A. PY - 2016 DA - 2016// TI - A efficacy and safety of tacrolimus therapy for active ulcerative colitis; a systematic review and meta-analysis JO - J Crohn's Colitis VL - 10 UR - https://doi.org/10.1093/ecco-jcc/jjv221 DO - 10.1093/ecco-jcc/jjv221 ID - Komaki2016 ER - TY - JOUR AU - Frøslie, K. F. AU - Jahnsen, J. AU - Vatn, M. H. PY - 2007 DA - 2007// TI - Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort JO - Gastroenterology. VL - 133 UR - https://doi.org/10.1053/j.gastro.2007.05.051 DO - 10.1053/j.gastro.2007.05.051 ID - Frøslie2007 ER - TY - JOUR AU - Schroeder, K. W. AU - Tremaine, W. J. AU - Ilstrup, D. M. PY - 1987 DA - 1987// TI - Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study JO - N Engl J Med VL - 317 UR - https://doi.org/10.1056/NEJM198712243172603 DO - 10.1056/NEJM198712243172603 ID - Schroeder1987 ER - TY - JOUR AU - Travis, S. P. AU - Schnell, D. AU - Sandborn, W. J. PY - 2013 DA - 2013// TI - Reliability and initial validation of the ulcerative colitis endoscopic index of severity JO - Gastroenterology. VL - 145 UR - https://doi.org/10.1053/j.gastro.2013.07.024 DO - 10.1053/j.gastro.2013.07.024 ID - Travis2013 ER - TY - JOUR AU - Lichtiger, S. AU - Present, D. H. AU - Hanauer, S. PY - 1994 DA - 1994// TI - Cyclosporine in severe ulcerative colitis refractory to steroid therapy JO - N Engl J Med VL - 330 UR - https://doi.org/10.1056/NEJM199406303302601 DO - 10.1056/NEJM199406303302601 ID - Lichtiger1994 ER - TY - STD TI - Bertani L, Bodini G, Francesco C, et al. Corticosteroid treatment at diagnosis: an analysis of relapses, disease extension, and colectomy rate in ulcerative colitis. Digest Dis Sci. 2019); PMID: 31754992. https://doi.org/10.1007/s10620-019-05959-y. ID - ref11 ER - TY - JOUR AU - Colombel, J. F. AU - Rutgeerts, P. AU - Sandborn, W. J. PY - 2011 DA - 2011// TI - Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis JO - Gastroenterology VL - 141 UR - https://doi.org/10.1053/j.gastro.2011.06.054 DO - 10.1053/j.gastro.2011.06.054 ID - Colombel2011 ER - TY - JOUR AU - Truelove, S. C. AU - Jewell, D. P. PY - 1974 DA - 1974// TI - Intensive intravenous regimen for severe attacks of ulcerative colitis JO - Lancet. VL - 1 UR - https://doi.org/10.1016/S0140-6736(74)90552-2 DO - 10.1016/S0140-6736(74)90552-2 ID - Truelove1974 ER - TY - JOUR AU - Testa, A. AU - Castiglione, F. AU - Colombo, G. L. PY - 2017 DA - 2017// TI - Adherence in ulcerative colitis: an overview JO - Patient Prefer Adherence VL - 22 UR - https://doi.org/10.2147/PPA.S127039 DO - 10.2147/PPA.S127039 ID - Testa2017 ER - TY - JOUR AU - Robinson, A. PY - 2008 DA - 2008// TI - Review article: improving adherence to medication in patients with inflammatory bowel disease JO - Aliment Pharmacol Ther VL - 27 UR - https://doi.org/10.1111/j.1365-2036.2008.03604.x DO - 10.1111/j.1365-2036.2008.03604.x ID - Robinson2008 ER - TY - JOUR AU - Faubion, W. A. AU - Loftus, E. V. AU - Sandborn, W. J. PY - 2001 DA - 2001// TI - The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study JO - Gastroenterology. VL - 121 UR - https://doi.org/10.1053/gast.2001.26279 DO - 10.1053/gast.2001.26279 ID - Faubion2001 ER - TY - JOUR AU - Khan, N. AU - Abbas, A. AU - Balart, L. PY - 2013 DA - 2013// TI - Prevalence of corticosteroids use and disease course after initial steroid exposure in ulcerative colitis JO - Dig Dis Sci VL - 58 UR - https://doi.org/10.1007/s10620-013-2748-0 DO - 10.1007/s10620-013-2748-0 ID - Khan2013 ER - TY - JOUR AU - Khan, N. H. AU - Almukhtar, R. M. AU - Abbas, A. M. PY - 2014 DA - 2014// TI - Early corticosteroids requirement after the diagnosis of ulcerative colitis diagnosis can predict a more severe long term course of the disease – a nationwide study of 1035 patients JO - Aliment Pharmacol Ther VL - 40 UR - https://doi.org/10.1111/apt.12834 DO - 10.1111/apt.12834 ID - Khan2014 ER - TY - JOUR AU - Buchman, A. L. PY - 2001 DA - 2001// TI - Side effects of corticosteroid therapy JO - J Clin Gastroenterol VL - 33 UR - https://doi.org/10.1097/00004836-200110000-00006 DO - 10.1097/00004836-200110000-00006 ID - Buchman2001 ER - TY - JOUR AU - Eugene, C. PY - 2012 DA - 2012// TI - Ulcerative colitis practice guidelines in adults JO - Clin Res Hepatol Gastroenterol VL - 36 UR - https://doi.org/10.1016/j.clinre.2011.12.005 DO - 10.1016/j.clinre.2011.12.005 ID - Eugene2012 ER - TY - JOUR AU - Miyoshi, J. AU - Iwao, Y. AU - Hibi, T. PY - 2013 DA - 2013// TI - Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients JO - J Crohns Colitis VL - 7 UR - https://doi.org/10.1016/j.crohns.2013.04.018 DO - 10.1016/j.crohns.2013.04.018 ID - Miyoshi2013 ER - TY - JOUR AU - Guthrie, E. AU - Jackson, J. AU - Creed, F. PY - 2002 DA - 2002// TI - Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease JO - Am J Gastroenterol VL - 97 UR - https://doi.org/10.1111/j.1572-0241.2002.05842.x DO - 10.1111/j.1572-0241.2002.05842.x ID - Guthrie2002 ER - TY - JOUR AU - Leong, R. W. AU - Lee, Y. T. AU - Sung, J. J. PY - 2003 DA - 2003// TI - Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the inflammatory bowel disease questionnaire JO - Aliment Pharmacol Ther VL - 17 UR - https://doi.org/10.1046/j.1365-2036.2003.01489.x DO - 10.1046/j.1365-2036.2003.01489.x ID - Leong2003 ER - TY - JOUR AU - Flechner, S. M. AU - Kobashigawa, J. AU - Klintmalm, G. PY - 2008 DA - 2008// TI - Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity JO - Clin Transplantation VL - 22 ID - Flechner2008 ER - TY - JOUR AU - Baumgart, D. C. AU - Pintoffl, J. P. AU - Dignass, A. U. PY - 2006 DA - 2006// TI - Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease a long-term follow-up JO - Am J Gastroenterol VL - 101 UR - https://doi.org/10.1111/j.1572-0241.2006.00524.x DO - 10.1111/j.1572-0241.2006.00524.x ID - Baumgart2006 ER - TY - JOUR AU - Li, J. AU - Zhao, X. AU - Zhang, H. PY - 2019 DA - 2019// TI - Systematic review with meta-analysis: fecal calprotectin as a surrogate marker for predicting relapse in adults with ulcerative colitis JO - Mediat Inflamm VL - 2019 UR - https://doi.org/10.1155/2019/2136501 DO - 10.1155/2019/2136501 ID - Li2019 ER -